Reports
Reports
Sale
The global colposcopy market size was valued at USD 611.82 million in 2023, driven by the increased prevalence of cervical cancer across the globe. The market is expected to grow at a CAGR of 6% during the forecast period of 2024-2032, with the values likely to rise from USD 648.41 million in 2024 to USD 1,031.91 million by 2032.
A colposcopy is a diagnostic procedure to check any abnormal tissue growth in the lower part of the uterus (cervix) and the wall of the vagina. The procedure, usually lasting for 10 to 20 minutes, employs a specialized microscope called a colposcope to magnify the tissue, lining the cervix and vagina. In case any abnormalities are detected, a biopsy is done to test the tissue for precancerous or cancerous cells. Besides checking for cancerous cells, colposcopies can also be used to test for noncancerous growth (polyps), genital warts, vulvar itching, or abnormal vaginal bleeding.
The rising incidence of cervical cancer is acting as the key driver for colposcopy market growth. According to the report released by the World Health Organization (WHO), cervical cancer is the fourth most common cancer in women worldwide. It is also reported that women with human papillomavirus (HPV) are 6 times more prone to cervical cancer as compared to the ones without HPV infection. In addition, it is estimated that around 600,000 women suffer from cervical cancer caused by the sexually transmitted infection HPV, which has prompted the demand for effective screening procedures including colposcopy globally. Moreover, the robust government support to raise awareness about cervical cancers and the importance of colposcopy is expected to bolster the market growth in the coming years.
Development of Novel Colposcopy Products for Cervical Cancer Screening
The recent advancements in technology led to the development of digital and portable colposcopes, facilitating enhanced imaging capabilities and convenience. Additionally, the integration of artificial intelligence (AI) has substantially improved the speed and accuracy of the screening method. This has resulted in a spike in the number of patients opting for the diagnostic procedure, fueling the colposcopy market demand.
In May 2023 , MobileODT, an AI-based FemTech company in Israel introduced EVAPro next gen digital colposcope featuring high image quality with superior software capabilities. The lightweight and portable colposcope utilizes artificial intelligence and machine learning for cervical cancer screening on a large scale, offering quick evaluation (under a minute) and instant consultation. Thus, the novel product redefines cervical cancer screening as compared to the existing standard of care.
Increased Government Initiatives and Awareness Campaigns
Initiatives to raise awareness about the importance of colposcopy for early detection of cervical cancer by government, non-profit organizations, and healthcare facilities have boosted the colposcopy market share significantly.
In May 2023, the National Health Service (NHS), a publicly funded healthcare system in England, pledged to eliminate cervical cancer by 2040. The initiative aims to improve the accessibility of online vaccine appointments and encourage more people to undergo cervical screening, with 3.5 million tested in the last year. With the help of colposcopy teams, and immunization staff, among others, the NHS is actively working towards reducing the global burden of cervical cancer. The robust campaigns are reaching a wider audience, prompting them to adopt regular cervical cancer screening practices, which is likely to contribute to notable market growth in the forecast period.
Market Breakup by Instrument Type
Market Breakup by Portability
Market Breakup by Applications
Market Breakup by End User
Market Breakup by Region
North America is anticipated to account for the largest share in the colposcopy market which can be attributed to the rapidly rising cases of cervical cancer in the region. Other key factors, like the technological advances in the healthcare sector, product launches of innovative colposcopes integrated with artificial intelligence, and the presence of pioneering medical device companies in the region are also expected to propel the growth of the market in the forecast period.
In Asia Pacific, various programs led by government and non-government organizations have bolstered the colposcopy market share, with the increased number of people seeking regular cervical cancer screening procedures including colposcopy. In November 2023 , the ROSE Foundation (a non-profit organization committed to eliminating cervical cancer in Malaysia) via its Program ROSE (Removing Obstacles to cervical ScrEening) celebrated a milestone in facilitating cervical cancer screening to over 25000 women, with 90% of women receiving appropriate follow-up examinations and treatments. To eliminate cervical cancer in Malaysia, the Foundation plans to implement a mobile colposcopy service in a remote village in Sarawak, a Malaysian state. The surge in such initiatives surrounding cervical cancer treatment are poised to elevate the application of colposcopes, boosting the market demand during the forecast period.
In November 2023 , Indonesia based medical devices companies such as PT Forsta Kalmedic Global, PT Kalgen DNA, PT Swayasa Prakarsa, and PT Prima Alkesindo Nusantara, made strategic collaborations and trade transactions amounting to IDR 363.08 billion (USD 21.5 million) during the 4 days of the world’s largest health equipment exhibition MEDICA 2023 event in Germany. The exhibition, boasting participation from over 6200 multinational companies, revealed the market expansion efforts of Indonesian medical device companies carrying a diverse product portfolio including colposcopy machines, bone graft equipment, etc. Such events of collaborations and investment are projected to increase the colposcopy market size in the forecast period.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Instrument Type |
|
Breakup by Portability |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Colposcopy Market (2017-2032) Overview
3.1 Global Colposcopy Market (2017-2032) Historical Value (2017-2023)
3.2 Global Colposcopy Market (2017-2032) Forecast Value (2024-2032)
4 Global Colposcopy Market (2017-2032) Landscape
4.1 Global Colposcopy Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Colposcopy Product Landscape
4.2.1 Analysis by Instrument Type
4.2.2 Analysis by Application
5 Global Colposcopy Market (2017-2032) Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Colposcopy Market (2017-2032) Segmentation
6.1 Global Colposcopy Market (2017-2032) by Instrument Type
6.1.1 Market Overview
6.1.2 Optical
6.1.3 Digital
6.2 Global Colposcopy Market (2017-2032) by Portability
6.2.1 Market Overview
6.2.2 Stationary
6.2.3 Handheld
6.3 Global Colposcopy Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Cervical Cancer Screening
6.3.3 Physical Examinations
6.3.4 Other Applications
6.4 Global Colposcopy Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals & Clinics
6.4.3 Diagnostic Centres
6.4.4 Others
6.5 Global Colposcopy Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Colposcopy Market (2017-2032)
7.1 North America Colposcopy Market (2017-2032) by Instrument Type
7.1.1 Market Overview
7.1.2 Optical
7.1.3 Digital
7.2 North America Colposcopy Market (2017-2032) by Portability
7.2.1 Market Overview
7.2.2 Stationary
7.2.3 Handheld
7.3 North Colposcopy Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Colposcopy Market (2017-2032)
8.1 Europe Colposcopy Market (2017-2032) by Instrument Type
8.1.1 Market Overview
8.1.2 Optical
8.1.3 Digital
8.2 Europe Colposcopy Market (2017-2032) by Portability
8.2.1 Market Overview
8.2.2 Stationary
8.2.3 Handheld
8.3 Europe Colposcopy Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Colposcopy Market (2017-2032)
9.1 Asia Pacific Colposcopy Market (2017-2032) by Instrument Type
9.1.1 Market Overview
9.1.2 Optical
9.1.3 Digital
9.2 Asia Pacific Colposcopy Market (2017-2032) by Portability
9.2.1 Market Overview
9.2.2 Stationary
9.2.3 Handheld
9.3 Asia Pacific Colposcopy Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Colposcopy Market (2017-2032)
10.1 Latin America Colposcopy Market (2017-2032) by Instrument Type
10.1.1 Market Overview
10.1.2 Optical
10.1.3 Digital
10.2 Latin America Colposcopy Market (2017-2032) by Portability
10.2.1 Market Overview
10.2.2 Stationary
10.2.3 Handheld
10.3 Latin America Colposcopy Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Colposcopy Market (2017-2032)
11.1 Middle East and Africa Colposcopy Market (2017-2032) by Instrument Type
11.1.1 Market Overview
11.1.2 Optical
11.1.3 Digital
11.2 Middle East and Africa Colposcopy Market (2017-2032) by Portability
11.2.1 Market Overview
11.2.2 Stationary
11.2.3 Handheld
11.3 Middle East and Africa Colposcopy Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 DYSIS Medical Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Olympus Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Kaps GmbH & Co. KG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Carl Zeiss AG
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 CooperSurgical, Inc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Koninklijke Philips N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 MedGyn Products, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Danaher Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Schmitz Cargobull AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Seiler Instrument Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 ATMOS MedizinTechnik GmbH & Co. KG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 MobileODT Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
List not exhaustive
18 Global Colposcopy Market (2017-2032) Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
The market attained a value of about USD 611.82 million in 2023 driven by the increased prevalence of cervical cancer across the globe.
The market is anticipated to grow at a CAGR of 6% during the forecast period of 2024-2032, likely to reach a market value of USD 1,031.91 million by 2032.
The growing awareness regarding colposcopy and cervix cancer as a result of initiatives led by government and healthcare organizations are some of the factors contributing to the increasing market demand.
The rise in product launches of novel colposcopes is one of the major trends driving the colposcopy market. In May 2023 , MobileODT, an AI-based FemTech company in Israel introduced EVAPro next gen digital colposcope featuring high image quality with superior software capabilities that utilize artificial intelligence and machine learning for cervical cancer screening on a large scale.
The market is divided into optical and digital colposcopes, based on the instrument type.
Based on portability, the market is segmented into stationary and handheld colposcopes.
Applications of colposcopy include cervical cancer screening and physical examinations, among other applications.
The major end users in the market include hospitals & clinics, and diagnostic centres, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa.
Key players involved in the market are DYSIS Medical Inc., Olympus Corporation, Kaps GmbH & Co. KG, Carl Zeiss AG, CooperSurgical, Inc, Koninklijke Philips N.V., MedGyn Products, Inc., Danaher Corporation, Schmitz Cargobull AG, Seiler Instrument Inc., ATMOS MedizinTechnik GmbH & Co. KG, and MobileODT Ltd.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.